Login

Exploring Global Ventures: An Interview with Marco Soriano, CEO of Soriano Group 00:10:00

Share On Facebook Share On Twitter

Marco Antonio SORIANO VII, CEO of The Soriano Group and its global subsidiaries

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Eagle Plains' Spin-Off and New Exploration Ventures: Tim Turmani on Royalties and the Vulcan Project
00:00:00
Paradigm Biopharma – executive interview - Paul Rennie, CEO, co-founder and chairman, Paradigm Biopharmaceuticals Ltd
00:10:00
Anastasia Amoroso, iCapital's Chief Investment Strategist, joins 'Squawk Box' to discuss recent market trends and insights from the Fed's latest decisions.
00:10:00
Keystone Law Group PLC: Full-Year Results | James Knight - Chief Executive Officer of Keystone Law.
00:10:00
Quebec Precious Metals Eyes Next Eleonore Mine at One-to-One Conference in New York
00:00:00
BOT Investor Webinar | 26 September 2023 - Vince Ippolito Executive Chairman, Botanix Pharmaceuticals Ltd
00:10:00
Inside Jane Street: Hospitality Team Insights with Simone
00:10:00
Hargreaves Services PLC: Interim Results - Nov '23 Update | Gordon Banham - Group Chief Executive of Hargreaves Services
00:10:00
Datasonic is ready to help the government create a special subsidy card equipped with a technological system to support the targeted subsidy mechanism | JENS MONTANANA, CEO, Datasonic Group BhdDSONIC:KLS
00:10:00
Dan Danford on Client-Centered Financial Advising at Family Investment Center | Dan Danford, CEO, Family Investment Center.
00:10:00
Callitas Health Inc. CEO James Thompson Discusses Upcoming Launch of CannaMint Strips and New Partnership for Arousal Gels
00:10:00
Enhancing Client Convenience Through E-Signing Capabilities

© 2026 Nehu